Leerink Swann Maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Addressing USPTO Interference For GILD/ IDIX Patent Claims
Go back to Leerink Swann Maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Addressing USPTO Interference For GILD/ IDIX Patent Claims| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.44 -4.16 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.60 | 52 Week High | $108.63 | |||
| Open | $146.69 | 52 Week Low | $71.39 | |||
| Day High | $146.82 | P/E | 79.25 | |||
| Day Low | $143.19 | EPS | $1.81 | |||
| Volume | 7,159,990 | |||||
| Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) | Delayed: 24.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.50 | 52 Week High | $24.50 | |||
| Open | $9.18 | 52 Week Low | $4.81 | |||
| Day High | $24.50 | P/E | N/A | |||
| Day Low | $24.50 | EPS | $-0.89 | |||
| Volume | 5,300 | |||||
